Analytical Research Cognizance has published report on “Global Next Generation Cancer Diagnostics Market Size Study, By Technology (NGS, LOAC and RT-PCR), By Application (CTC, Biomarker, Proteomic), By Cancer Type (Lung, Breast), By Function Companion Diagnostics) and Regional Forecasts, 2017-2025” with Detailed Research and Segmented Analysis.
Manhattan, United States – October 12, 2018 —
Global Next Generation Cancer Diagnostics Market to reach USD 14.5 billion by 2025.
Global Next Generation Cancer Diagnostics Market is valued approximately USD 5.8 billion in 2016 and is expected to grow at 16.5% CAGR during the forecast period. Owing to the early diagnosis and more précised prognosis of various types of cancer, the next generation cancer diagnostics are gaining faster adoption. Moreover, increasing cases of oncology and advancements in genomics research are primarily driving the market growth.
Request Sample of Next Generation Cancer Diagnostics Market Report @ http://www.arcognizance.com/enquiry-sample/120348
The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the global infertility treatment market are given below:
• NGS-based cancer diagnostics
• qPCR & Multiplexing
• Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
• Protein microarrays-based cancer diagnostics
• DNA microarrays-based cancer diagnostics
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Biomarker Development
• CTC Analysis
• Proteomic Analysis
• Epigenetic Analysis
• Genetic Analysis
• Therapeutic Monitoring
• Companion Diagnostics
• Prognostic Diagnostics
• Cancer Screening
• Risk Analysis
• North America
• Asia Pacific
• Rest of the World
Furthermore, the years considered for the study are as follows:
• Historical year – 2015
• Base year – 2016
• Forecast period – 2017 to 2025
Access Next Generation Cancer Diagnostics Market Full Report @ https://tinyurl.com/y74ey6bg
Some of the key manufacturers involved in the market are; Novartis AG, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Abbott , GE Healthcare , Thermo Fisher Scientific, Inc.
Target Audience of the Next Generation Cancer Diagnostics Market Study
• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
Please note, that owing to the criticality of the Next Generation Cancer Diagnostic industry and rapidly changing market attributes, we are the middle of updating the report. The final report may require 2 to 3 working days post-confirmation in o
• Agilent Technologies (Dako)
• Almac Group
• F. Hoffmann-La Roche Ltd
• GE Healthcare
• Illumina, Inc.
• Janssen Global Services, LLC
• Koninklijke Philips N.V.
• Novartis AG
• Perkin Elmer, Inc.
• Thermo Fisher Scientific, Inc.
Order Purchase copy of Next Generation Cancer Diagnostics Market Report @ http://www.arcognizance.com/purchase/120348
Important Points from Table of Content:
• Global Next Generation Cancer Diagnostics Market Definition and Scope
• Research Methodology
• Executive Summary
• Global Next Generation Cancer Diagnostics Market Dynamics
• Global Next Generation Cancer Diagnostics Market, By Component
• Global Next Generation Cancer Diagnostics Market, By End User
• Global Next Generation Cancer Diagnostics Market, By Application
• Global Next Generation Cancer Diagnostics Market, by Regional Analysis
• Competitive Intelligence
www.arcognizance.com is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics” based on the data collection facilities of big data, the face of “business research facilities” has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, Market reports, and forecasts that are talking about the “out of the box” developments in the Market.
Name: Matt Wilson
Organization: Analytical Research Cognizance
This content is produced independently of Reuters Editorial News. For content inquiry, please contact firstname.lastname@example.org
This news is published on Reuters.